Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
ASCP Corner
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Martin Dossenbach, MD
JCP
Original Research
Long-Term Antipsychotic Monotherapy for Schizophrenia: Disease Burden and Comparative Outcomes for Patients Treated With Olanzapine, Quetiapine, Risperidone, or Haloperidol Monotherapy in a Pan-Continental Observational Study
December 31, 2008
Martin Dossenbach
,
Jan Pecenak
,
Agata Szulc
, et al
JCP
Original Research
Frequency of Painful Physical Symptoms With Major Depressive Disorder in Asia: Relationship With Disease Severity and Quality of Life
December 2, 2008
Phil Lee
,
Mingyuan Zhang
,
Jin Pyo Hong
, et al
JCP
Original Research
Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study
August 15, 2005
Martin Dossenbach
,
Cesar Arango-Dávila
,
Hernan Silva Ibarra
, et al
JCP
Original Research
Effectiveness of Antipsychotic Treatments for Schizophrenia: Interim 6-Month Analysis From a Prospective Observational Study (IC-SOHO) Comparing Olanzapine, Quetiapine, Risperidone, and Haloperidol
March 1, 2004
Martin Dossenbach
,
Almila Erol
,
Mohand el Mahfoud Kessaci
, et al
